Literature DB >> 22087182

Broader use of hepatitis B virus vaccine: Efficacy in those who lost hepatitis B surface antigen during follow-up.

Rakesh Kumar1, Babita Agrawal.   

Abstract

Entities:  

Keywords:  Hepatitis B surface antigen; Hepatitis B vaccine; Liver fibrosis

Year:  2011        PMID： 22087182      PMCID： PMC3212784     

Source DB:  PubMed          Journal:  Hepat Mon        ISSN： 1735-143X            Impact factor:   0.660


× No keyword cloud information.
  5 in total

Review 1.  Occult hepatitis B: clinical implications and treatment decisions.

Authors:  Paul Schmeltzer; Kenneth E Sherman
Journal:  Dig Dis Sci       Date:  2010-10-07       Impact factor: 3.199

2.  Elimination of hepatitis B virus surface antigen and appearance of neutralizing antibodies in chronically infected patients without viral clearance.

Authors:  Z-H Zhang; L Li; X-P Zhao; D Glebe; C M Bremer; Z-M Zhang; Y-J Tian; B-J Wang; Y Yang; W Gerlich; M Roggendorf; X Li; M Lu; D-L Yang
Journal:  J Viral Hepat       Date:  2010-08-31       Impact factor: 3.728

3.  [A study of immune response to hepatitis B vaccine & HBV DNA in isolated anti-HBc positive subjects].

Authors:  Hee Jeong Koh; Soon Duck Kim; Ji Ho Choi; Sung Ryul Kim; Jin Soo Lee
Journal:  J Prev Med Public Health       Date:  2005-05

4.  Efficacy of Hepatitis B vaccine in those who lost Hepatitis B surface antigen during follow-up: Efficacy of HBV vaccine in those who lost HBsAg.

Authors:  Hassan Taheri; Mohammad Reza Hasanjani Roushan; Mohammad Jafar Soleimani Amiri; Mohammad Pouralijan; Ali Bijani
Journal:  Hepat Mon       Date:  2011-02       Impact factor: 0.660

5.  Dilemma of HBsAg seroconversion in chronic hepatitis B infection: Dilemma of HBsAg in chronic HBV.

Authors:  Seyed Moayed Alavian; Seyed Mohammad Miri
Journal:  Hepat Mon       Date:  2011-02       Impact factor: 0.660
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.